BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...Inc. (NASDAQ:NVAX) named Rick Crowley EVP and COO. Crowley, who was EVP, technical operations at TerSera Therapeutics LLC...
BioCentury | Mar 10, 2017
Company News

AZ, TerSera deal

...AstraZeneca granted TerSera rights to commercialization Zoladex goserelin in the U.S. and Canada. AZ will receive...
...$70 million in milestones, plus mid-teen royalties. AZ will manufacture and supply the drug to TerSera...
...plc (LSE:AZN; NYSE:AZN), London, U.K. TerSera Therapeutics LLC , Cedar Rapids, Iowa Business: Cancer, Endocrine/Metabolic Chris Lieu Zoladex AstraZeneca plc GnRH/LHRH receptor TerSera Therapeutics LLC...
Items per page:
1 - 2 of 2
BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...Inc. (NASDAQ:NVAX) named Rick Crowley EVP and COO. Crowley, who was EVP, technical operations at TerSera Therapeutics LLC...
BioCentury | Mar 10, 2017
Company News

AZ, TerSera deal

...AstraZeneca granted TerSera rights to commercialization Zoladex goserelin in the U.S. and Canada. AZ will receive...
...$70 million in milestones, plus mid-teen royalties. AZ will manufacture and supply the drug to TerSera...
...plc (LSE:AZN; NYSE:AZN), London, U.K. TerSera Therapeutics LLC , Cedar Rapids, Iowa Business: Cancer, Endocrine/Metabolic Chris Lieu Zoladex AstraZeneca plc GnRH/LHRH receptor TerSera Therapeutics LLC...
Items per page:
1 - 2 of 2